| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |